Netherlands

MLA Diagnostics from Netherlands secures 7-Figure Funding for personalized Skin Cancer Treatment Clinical Trials
MLA Diagnostics, headquartered in the Netherlands and specializing in improving tailored treatments for skin cancer, has recently obtained new funding to progress its development and initiate clinical trials.

The best Articles in our Network

Previous
Next